Infant
Conditions
Interventions
Experimental group: 11 preterm newborns undergoing non-invasive ventilation will receive nasal protection with hydrocolloid, columella and nasal septum until medical suspension of this ventilatory sup
Device
E07.101.074
D02.715.650.700.755
Sponsors
Universidade Tecnológica Federal do Paraná
Hospital Infantil Waldemar Monastier
Eligibility
Age
No minimum to 37 Weeks
Inclusion criteria
Inclusion criteria: Preterm newborn of both genders. Preterm newborn without distinction of ethnicity. Preterm newborn without distinction of class or social group. Preterm newborn with gestational age of less than 37 weeks were submitted to non-invasive ventilation through binasal prongs as initial ventilatory support or as weaning for a minimum of 24 hours. Preterm newborn that the parents and / or guardians sign the Informed Consent Term.
Exclusion criteria
Exclusion criteria: Term neonates. Newborns with nasal deformities. Newborns on non-invasive ventilation for a period of less than 24 hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1. Prevention of nasal lesion with the use of hydrocolloid, verified by daily clinical inspection of the nostrils, from the incidence of 0% nasal lesion, comparing the pre and post intervention measurements.;Outcome found 1. Occurrence of nasal lesion even with the preventive use of hydrocolloid, verified through daily clinical inspection, based on the incidence of nasal lesion of 36.36%, comparing the pre and post intervention measurements.;Expected outcome 2. Prevention of nasal lesions with the use of thick silicone gel, verified through daily clinical inspection of the nostrils, from the incidence of nasal lesion of 0%, comparing the pre and post intervention measurements.;Outcome found 2. Occurrence of nasal lesion even with the preventive use of thick silicone gel, verified through daily clinical inspection, from the incidence of nasal lesion of 81.81%, comparing the pre and post intervention measurements.;Expected outcome 3. Prevention of nasal lesion with the use of thin silicone gel, verified by daily clinical inspection of the nostrils, from the incidence of 0% nasal lesion, comparing the pre and post intervention measurements.;Outcome found 3. Occurrence of nasal lesion even with the preventive use of thin silicone gel, verified through daily clinical inspection, based on the incidence of nasal lesion of 72.72%, comparing the pre and post intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1. Non-detachment of the hydrocolloid, verified by daily clinical inspection of the nostrils, from the mean change in protection of 0.00 times during the intervention period.;Outcome found 1. No hydrocolloid detachment, verified by daily clinical inspection of the nostrils, from the mean change of 0.00 times during the intervention period.;Expected outcome 2. Non-detachment of the thick silicone gel, verified by means of the daily clinical inspection of the nostrils, from the average protection change of 0.00 times during the intervention period.;Outcome found 2. Detachment of the thick silicone gel, verified through daily clinical inspection of the nostrils, from the mean change of 3.22 times during the intervention period.;Expected outcome 3. Non-detachment of the thin silicone gel, verified by means of daily clinical inspection of the nostrils, from the mean change of protection of 0.00 times during the intervention period.;Outcome found 3. Detachment of the thin silicone gel, verified through daily clinical inspection of the nostrils, from the mean change of 1.50 times during the intervention period. | — |
Countries
Brazil
Contacts
Public ContactDébora Ribeiro
Debora de fátima camillo ribeiro
Outcome results
None listed